BMT, Gamida Cell Ltd, malignancies hematologic, Omidubicel
Omidubicel disatujuan ku USFDA pikeun ngirangan waktos pikeun pamulihan neutrofil sareng inféksi dina pasien anu malignancies hematologis.
Méi 2023: Omidubicel-onlv (Omisirge, Gamida Cell Ltd.) disatujuan ku Administrasi Pangan sareng Narkoba pikeun dianggo dina pasien dewasa sareng murangkalih (umur 12 taun sareng langkung lami) kalayan malignancies hematologic anu dijadwalkeun pikeun nampi.
Béta Thalassemia, BMT, Covid-19, India, Talasemia
Béta Thalassemia sareng pertimbanganana sareng COVID-19
Juli 2021: Beta-thalassemia mangrupikeun kaayaan turunan anu disababkeun ku mutasi gén anu kalibet dina produksi komponén hémoglobin, protéin anu ngangkut oksigén ka sakumna awak. Mutasi ieu boh ngalarang ..
BMT, Transper sungsum tulang, Cangkok sél gagang
Cangkok sungsum tulang di India
Bone marrow transplant in India Bone marrow stem cell transplants in India are performed by some of the leading cancer centres. To date, more than 10,000 successful bone marrow stem cell transplants have been performed in India. ..